It follows that Wyeth would need to have any claim for interlocutory relief determined by no later than 1 July 2009 to avoid passing on a reduction of 12.5% in the price of Efexor-XR. The second consideration is that an applicant must show that the order is necessary in the interests of justice. The first was whether Wyeth had made reasonable inquiries. Wyeth was not provided with the names of the applicants. The application to the Court seeks identity discovery under O 15A r 3 and information discovery under O 15A r 6.